QRONS
Qrons is a publicly-traded, preclinical biotechnology company that develops advanced cell-based solutions to combat neurological injuries. While they are laser-focused on traumatic brain injury (TBI), their technology could potentially treat a wide range of neurodegenerative diseases. Their TBI treatment integrates proprietary, engineered mesenchymal stem cells (MSCs), 3D printable scaffolding, smart materials, and a novel delivery system. They believe this combination will reduce neuronal loss and functional impairment and possibly regenerate brain tissue and function for TBI patients. It was founded in 2016 and is headquartered in New York, New York.
QRONS
Industry:
Biotechnology
Founded:
2016-01-01
Address:
New York, New York, United States
Country:
United States
Website Url:
http://www.qrons.com
Total Employee:
1+
Status:
Active
Contact:
786.620.2140
Email Addresses:
[email protected]
Total Funding:
500 K USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt WordPress Font Awesome Wordpress Plugins Nginx
Similar Organizations
Passage Bio
Passage Bio is a fully integrated gene therapy company developing therapies for the treatment of monogenic central nervous system diseases.
Scholar Rock
Scholar Rock is a biopharmaceutical company that develops and discovers new medicines and treatments for the serious diseases.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Official Site Inspections
http://www.qrons.com
- Host name: 146.39.196.104.bc.googleusercontent.com
- IP address: 104.196.39.146
- Location: United States
- Latitude: 38.6583
- Longitude: -77.2481
- Timezone: America/New_York
